Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
Authors
Keywords
-
Journal
ANNALS OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
Publisher
American College of Physicians
Online
2022-08-16
DOI
10.7326/m22-1079
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
- (2022) Philippe Bégin et al. NATURE MEDICINE
- Effect of convalescent plasma as complementary treatment in patients with moderate COVID ‐19 infection
- (2022) Manuel E. Baldeón et al. TRANSFUSION MEDICINE
- A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
- (2022) Yogiraj Ray et al. Nature Communications
- Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial
- (2022) Shmuel Shoham et al. CLINICAL INFECTIOUS DISEASES
- Early Outpatient Treatment for Covid-19 with Convalescent Plasma
- (2022) David J. Sullivan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
- (2022) Maggie Li et al. Blood Advances
- COVID-19 convalescent plasma and the SARS-CoV-2 neutralizing titer
- (2021) Evan M Bloch et al. JOURNAL OF INFECTIOUS DISEASES
- Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
- (2021) Romina Libster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID ‐19 convalescent plasma: Interim recommendations from the AABB
- (2021) Claudia S. Cohn et al. TRANSFUSION
- Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York
- (2021) Elliott Bennett-Guerrero et al. CRITICAL CARE MEDICINE
- A randomized clinical trial evaluating the immunomodulatory effect of convalescent plasma on COVID-19-related cytokine storm
- (2021) Mandana Pouladzadeh et al. Internal and Emergency Medicine
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
- (2021) Harini Natarajan et al. mBio
- Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
- (2021) Manaf AlQahtani et al. Scientific Reports
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- (2021) Leo Sekine et al. EUROPEAN RESPIRATORY JOURNAL
- Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
- (2021) Meagan P. O’Brien et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Convalescent Plasma for High-Risk Outpatients with Covid-19
- (2021) Frederick K. Korley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
- (2021) Arvind Gharbharan et al. Nature Communications
- Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis
- (2021) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
- (2021) Bruce Kirenga et al. BMJ Open Respiratory Research
- COVID-19 Convalescent plasma
- (2021) Aaron Tobian et al. BLOOD
- Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
- (2021) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
- (2021) Mila B. Ortigoza et al. JAMA Internal Medicine
- Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia
- (2021) Francesco Menichetti et al. JAMA Network Open
- Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden
- (2021) Karin Holm et al. BMC Research Notes
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
- (2020) Stefan Schandelmaier et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
- (2020) Michael J. Joyner et al. MAYO CLINIC PROCEEDINGS
- Patient Trajectories Among Persons Hospitalized for COVID-19
- (2020) Brian T. Garibaldi et al. ANNALS OF INTERNAL MEDICINE
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
- (2020) Sabra L. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
- (2020) Sarah E Benner et al. JOURNAL OF INFECTIOUS DISEASES
- Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
- (2020) Anup Agarwal et al. BMJ-British Medical Journal
- Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
- (2020) Eric Salazar et al. AMERICAN JOURNAL OF PATHOLOGY
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
- (2020) Ventura A. Simonovich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
- (2020) Tania S Bonny et al. Open Forum Infectious Diseases
- Prevention of transfusion transmitted infections
- (2019) Michael P. Busch et al. BLOOD
- Clinical Practice Guidelines From the AABB
- (2016) Jeffrey L. Carson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
- (2016) Pablo Alonso-Coello et al. BMJ-British Medical Journal
- GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction
- (2016) Pablo Alonso-Coello et al. BMJ-British Medical Journal
- Platelet Transfusion: A Clinical Practice Guideline From the AABB
- (2015) Richard M. Kaufman et al. ANNALS OF INTERNAL MEDICINE
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started